Concepts (185)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2019 | 643 | 2.330 |
Why?
|
| Sphingosine N-Acyltransferase | 4 | 2015 | 62 | 1.680 |
Why?
|
| Sphingomyelin Phosphodiesterase | 4 | 2019 | 183 | 1.470 |
Why?
|
| Brain Injuries | 3 | 2019 | 268 | 1.310 |
Why?
|
| Oligodendroglia | 6 | 2017 | 107 | 1.070 |
Why?
|
| Photochemotherapy | 4 | 2013 | 59 | 1.020 |
Why?
|
| Membrane Proteins | 3 | 2015 | 617 | 0.990 |
Why?
|
| Nerve Tissue Proteins | 4 | 2014 | 290 | 0.850 |
Why?
|
| Glutamic Acid | 3 | 2017 | 332 | 0.760 |
Why?
|
| Ceramides | 7 | 2015 | 578 | 0.750 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2013 | 624 | 0.730 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 61 | 0.660 |
Why?
|
| Head and Neck Neoplasms | 4 | 2013 | 561 | 0.650 |
Why?
|
| Sphingosine | 4 | 2014 | 315 | 0.580 |
Why?
|
| Reperfusion Injury | 3 | 2009 | 320 | 0.580 |
Why?
|
| Stem Cells | 2 | 2010 | 248 | 0.570 |
Why?
|
| Lactosylceramides | 1 | 2016 | 27 | 0.540 |
Why?
|
| Sirtuin 3 | 1 | 2015 | 6 | 0.540 |
Why?
|
| Mitochondria, Heart | 1 | 2016 | 53 | 0.530 |
Why?
|
| Recovery of Function | 1 | 2019 | 506 | 0.510 |
Why?
|
| Oxidoreductases | 3 | 2013 | 117 | 0.500 |
Why?
|
| Alkaline Ceramidase | 1 | 2014 | 35 | 0.470 |
Why?
|
| Myelin Proteolipid Protein | 4 | 2006 | 20 | 0.460 |
Why?
|
| RNA, Small Interfering | 3 | 2013 | 434 | 0.460 |
Why?
|
| Cell Movement | 2 | 2007 | 630 | 0.450 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 113 | 0.450 |
Why?
|
| Brain | 3 | 2014 | 2176 | 0.440 |
Why?
|
| Gene Knockdown Techniques | 4 | 2016 | 196 | 0.410 |
Why?
|
| Apoptosis | 5 | 2015 | 1641 | 0.410 |
Why?
|
| Mice | 11 | 2019 | 8474 | 0.400 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2016 | 529 | 0.390 |
Why?
|
| Animals | 17 | 2019 | 20880 | 0.380 |
Why?
|
| Calcium | 3 | 2010 | 929 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2791 | 0.320 |
Why?
|
| Integrins | 1 | 2008 | 115 | 0.310 |
Why?
|
| src-Family Kinases | 1 | 2008 | 91 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2007 | 8 | 0.300 |
Why?
|
| Rats | 9 | 2017 | 5300 | 0.300 |
Why?
|
| Second Messenger Systems | 1 | 2007 | 53 | 0.300 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2007 | 63 | 0.280 |
Why?
|
| Integrin alphaV | 1 | 2006 | 3 | 0.280 |
Why?
|
| Mice, Knockout | 4 | 2015 | 1692 | 0.260 |
Why?
|
| Enzyme Activation | 3 | 2019 | 791 | 0.240 |
Why?
|
| Neutral Ceramidase | 2 | 2016 | 27 | 0.230 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2673 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 2083 | 0.200 |
Why?
|
| Brain Ischemia | 1 | 2007 | 665 | 0.200 |
Why?
|
| DNA Primers | 2 | 2012 | 302 | 0.170 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 22 | 0.170 |
Why?
|
| Mitochondria, Liver | 2 | 2011 | 148 | 0.160 |
Why?
|
| Hydrolysis | 2 | 2016 | 144 | 0.160 |
Why?
|
| Sphingomyelins | 2 | 2009 | 106 | 0.150 |
Why?
|
| Base Sequence | 2 | 2012 | 1015 | 0.150 |
Why?
|
| Necrosis | 1 | 2017 | 239 | 0.140 |
Why?
|
| Cell Respiration | 1 | 2016 | 47 | 0.130 |
Why?
|
| Indoles | 2 | 2013 | 146 | 0.130 |
Why?
|
| Caspase 3 | 2 | 2013 | 233 | 0.130 |
Why?
|
| Cognition | 1 | 2019 | 512 | 0.120 |
Why?
|
| Male | 10 | 2016 | 37283 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 282 | 0.120 |
Why?
|
| Sphingolipids | 3 | 2013 | 337 | 0.120 |
Why?
|
| Electron Transport Complex IV | 1 | 2014 | 33 | 0.120 |
Why?
|
| Myelin Sheath | 2 | 2006 | 115 | 0.120 |
Why?
|
| Cell Line, Tumor | 3 | 2013 | 1851 | 0.110 |
Why?
|
| Oxidative Stress | 2 | 2015 | 718 | 0.110 |
Why?
|
| Thiazoles | 1 | 2013 | 95 | 0.110 |
Why?
|
| Models, Biological | 2 | 2008 | 981 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2012 | 447 | 0.110 |
Why?
|
| Trypan Blue | 1 | 2012 | 24 | 0.110 |
Why?
|
| Hypoxia | 2 | 2004 | 169 | 0.100 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2014 | 200 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2013 | 178 | 0.100 |
Why?
|
| Peptide Hydrolases | 1 | 2012 | 82 | 0.100 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 93 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2012 | 254 | 0.100 |
Why?
|
| Pregnancy | 1 | 2017 | 2334 | 0.100 |
Why?
|
| Palmitoyl Coenzyme A | 1 | 2011 | 11 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 381 | 0.100 |
Why?
|
| Cell Death | 2 | 2009 | 329 | 0.100 |
Why?
|
| Heart | 1 | 2016 | 850 | 0.100 |
Why?
|
| Transfection | 1 | 2012 | 782 | 0.090 |
Why?
|
| Humans | 7 | 2015 | 68549 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2011 | 186 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2006 | 954 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2013 | 1663 | 0.090 |
Why?
|
| Calpain | 1 | 2010 | 205 | 0.090 |
Why?
|
| Homeostasis | 1 | 2010 | 291 | 0.080 |
Why?
|
| Integrin alpha6beta1 | 1 | 2008 | 4 | 0.080 |
Why?
|
| Receptors, Vitronectin | 1 | 2008 | 11 | 0.080 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 15 | 0.080 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2008 | 41 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 710 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2008 | 45 | 0.080 |
Why?
|
| Electron Transport | 1 | 2007 | 37 | 0.070 |
Why?
|
| Peripheral Nervous System | 1 | 2006 | 12 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 67 | 0.070 |
Why?
|
| Coculture Techniques | 1 | 2007 | 147 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2007 | 139 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2006 | 1174 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2007 | 137 | 0.070 |
Why?
|
| Cholinergic Agonists | 1 | 2006 | 5 | 0.070 |
Why?
|
| Ruthenium Red | 1 | 2006 | 5 | 0.070 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2006 | 14 | 0.070 |
Why?
|
| Egtazic Acid | 1 | 2006 | 29 | 0.070 |
Why?
|
| Thapsigargin | 1 | 2006 | 18 | 0.070 |
Why?
|
| Ionophores | 1 | 2006 | 25 | 0.070 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2006 | 21 | 0.070 |
Why?
|
| Carbachol | 1 | 2006 | 34 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2006 | 17 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 107 | 0.070 |
Why?
|
| Pertussis Toxin | 1 | 2006 | 72 | 0.070 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 63 | 0.070 |
Why?
|
| Mitochondrial Diseases | 1 | 2006 | 24 | 0.070 |
Why?
|
| Kainic Acid | 1 | 2006 | 44 | 0.070 |
Why?
|
| Chelating Agents | 1 | 2006 | 47 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 132 | 0.070 |
Why?
|
| Fibronectins | 1 | 2006 | 130 | 0.070 |
Why?
|
| Quinoxalines | 1 | 2006 | 78 | 0.070 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 99 | 0.070 |
Why?
|
| Cell Survival | 1 | 2008 | 901 | 0.060 |
Why?
|
| Lysophospholipids | 1 | 2007 | 209 | 0.060 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2006 | 128 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 134 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2006 | 289 | 0.060 |
Why?
|
| Benzodiazepines | 1 | 2006 | 130 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2006 | 396 | 0.060 |
Why?
|
| Axons | 1 | 2006 | 139 | 0.060 |
Why?
|
| Multiple Sclerosis | 1 | 2006 | 132 | 0.060 |
Why?
|
| Female | 4 | 2017 | 38021 | 0.060 |
Why?
|
| Kidney | 1 | 2009 | 945 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 1040 | 0.060 |
Why?
|
| Liver | 1 | 2009 | 1118 | 0.060 |
Why?
|
| Pelizaeus-Merzbacher Disease | 1 | 2003 | 1 | 0.060 |
Why?
|
| Myocardium | 1 | 2009 | 1204 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2006 | 659 | 0.050 |
Why?
|
| Respiration | 1 | 2003 | 91 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1745 | 0.050 |
Why?
|
| Mutation | 1 | 2004 | 1213 | 0.040 |
Why?
|
| Neurofilament Proteins | 2 | 2006 | 20 | 0.030 |
Why?
|
| Receptors, GABA-A | 2 | 2006 | 89 | 0.030 |
Why?
|
| Annexin A5 | 1 | 2013 | 16 | 0.030 |
Why?
|
| Propidium | 1 | 2013 | 26 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2013 | 24 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 31 | 0.030 |
Why?
|
| Abdominal Neoplasms | 1 | 2013 | 22 | 0.030 |
Why?
|
| Dasatinib | 1 | 2013 | 17 | 0.030 |
Why?
|
| Hypercapnia | 2 | 2004 | 17 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2013 | 134 | 0.030 |
Why?
|
| Brain Stem | 2 | 2004 | 46 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2006 | 328 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 195 | 0.030 |
Why?
|
| Acid Ceramidase | 1 | 2013 | 85 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 1033 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 170 | 0.030 |
Why?
|
| Palmitoyl-CoA Hydrolase | 1 | 2011 | 3 | 0.020 |
Why?
|
| Peptaibols | 1 | 2011 | 3 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2004 | 266 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 331 | 0.020 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2008 | 4 | 0.020 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2008 | 13 | 0.020 |
Why?
|
| Cyclophilins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 756 | 0.020 |
Why?
|
| Mice, Jimpy | 1 | 2006 | 5 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 54 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2006 | 33 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 92 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 88 | 0.020 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2006 | 7 | 0.020 |
Why?
|
| Postmortem Changes | 1 | 2006 | 15 | 0.020 |
Why?
|
| Glutamate Decarboxylase | 1 | 2006 | 18 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2006 | 57 | 0.020 |
Why?
|
| Parvalbumins | 1 | 2006 | 29 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2006 | 63 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 201 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 127 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2006 | 244 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2006 | 308 | 0.020 |
Why?
|
| Point Mutation | 1 | 2003 | 97 | 0.010 |
Why?
|
| Cell Count | 1 | 2003 | 248 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2003 | 323 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 1200 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 881 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2550 | 0.010 |
Why?
|
| Aged | 1 | 2006 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2006 | 21119 | 0.000 |
Why?
|